Kolexia
Cros Jerome
Anatomie et cytologie
Hôpital Beaujon
Clichy, France
280 Activités
375 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du pancréas Adénocarcinome Tumeurs neuroendocrines Carcinome du canal pancréatique Carcinomes Métastase tumorale Tumeurs kystiques, mucineuses et séreuses Récidive tumorale locale Tumeurs du foie

Industries

B3TSI
12 collaboration(s)
Dernière en 2021
Zeste Research
4 collaboration(s)
Dernière en 2021
M3 Global Research Ltd
3 collaboration(s)
Dernière en 2020
Adept Field Solutions
2 collaboration(s)
Dernière en 2023

Dernières activités

Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms.
Surgical endoscopy   06 mars 2024
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.
Nature medicine   29 janvier 2024
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
European journal of endocrinology   16 décembre 2023
Teduglutide (TED) enhances intestinal mitochondrial function in adult patients with short bowel syndrome (SBS)
Clinical nutrition ESPEN   01 décembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
Predictive clinical and imaging features of high-grade dysplasia in mucinous cystic neoplasms of the pancreas
European Pancreatic Club 2023 Abstracts   05 novembre 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy.
The lancet. Gastroenterology & hepatology   19 octobre 2023
1182O Temozolomide treatment induces an MMR-dependent hypermutator phenotype in well differentiated pancreatic neuroendocrine tumors
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
NIPICOL: Interest of iRECIST Radiological Assessment for Disease Control Rate (DCR) for Evaluation of Patients With Metastatic Colorectal Cancer dMMR and/or MSI Treated With Nivolumab and Ipilimumab. A GERCOR Open-label Phase II Study NIPICOL C17-01
Essai Clinique (BMS)   26 septembre 2023
High Tumor Uptake on F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   31 août 2023